Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q28244389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

4 January 2020

main subject

schizophrenia

0 references

phase II clinical trial

0 references

corrigendum / erratum

0 references

author

Boris V Andreev

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Leonid M. Bardenstein

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Margarita Morozova

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Sergey N. Mosolov

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Anatoly B. Smulevich

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Sandeep T Patil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lu Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ferenc Martenyi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Stephen L Lowe

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kimberley A Jackson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Alla S Avedisova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Issak Y Gurovich

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Nikolai G Neznanov

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Alexander M Reznik

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Vladimir A Tochilov

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Bryan G Johnson

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

James A Monn

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Darryle D Schoepp

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

language of work or name

English

0 references

publication date

2 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

1102-1107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

Diagnosis and classification of schizophrenia

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

The new generation of antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxyli

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

The potential role of lamotrigine in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Preclinical pharmacology of mGlu2/3 receptor agonists: novel agents for schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: an electrochemical and behavioural study

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Modulation of group II metabotropic glutamate receptor signaling by chronic cocaine

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Neuroprotective activity of metabotropic glutamate receptor ligands.

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.

1 reference

https://api.crossref.org/works/10.1038%2FNM1632

7 January 2021

Identifiers

DOI

10.1038/NM1632

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17767166%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017